Applied DNA Sciences to Present at Upcoming Investor Conferences
May 12 2017 - 11:45AM
Business Wire
Applied DNA Sciences, Inc. (“Applied DNA") (NASDAQ:APDN), a
provider of DNA-based supply chain, anti-counterfeiting and
anti-theft technology, product genotyping and DNA mass production
for diagnostics, announced that Dr. James Hayward, president &
CEO, will participate in two upcoming investor conferences:
- 18th Annual B. Riley
Institutional Investor Conference in Santa Monica on Wednesday,
May 24 and Thursday, May 25. Dr. Hayward is scheduled to present on
Wednesday, May 24 at 3:30pm PT and will host one-on-one meeting
throughout the two days.
- 7th Annual LD Micro
Invitational Conference in Los Angeles on Tuesday, June 6 and
Wednesday, June 7. Dr. Hayward is scheduled to present on Tuesday,
June 6 at 10:30am PT and will host one-on-one meeting throughout
the two days.
Dr. Hayward’s presentation at each conference will be webcast
through the Investor Relations section of the company's website
at www.adnas.com.
About Applied DNA Sciences
Applied DNA Sciences makes life real and safe by providing
innovative, molecular-based technology solutions and services that
can help protect products, brands, entire supply chains, and
intellectual property of companies, governments and consumers from
theft, counterfeiting, fraud and diversion. The proprietary
DNA-based “CertainTTM” platform can be used to identify, tag,
track, and trace products, to help assure authenticity, origin,
traceability and quality of products. SigNature® DNA describes the
core technology ingredient that is at the heart of a family of
uncopyable, security and authentication solutions such as
SigNature® T and fiberTyping®, targeted toward textiles and
apparel, BackTrac™and DNAnet®, for anti-theft and loss prevention,
and digitalDNA®, providing powerful track- and-trace. All provide a
forensic chain of evidence, and can be used to prosecute
perpetrators. Applied DNA Sciences is also engaged in the
large-scale production of specific DNA sequences using the
polymerase chain reaction.
Go to adnas.com for more information, events and to learn more
about how Applied DNA Sciences makes life real and safe. Common
stock listed on NASDAQ under the symbol APDN, and warrants are
listed under the symbol APDNW.
Forward-Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
6, 2016, and our subsequent quarterly reports on Form 10-Q filed on
February 9, 2017 and May 11, 2017, which are available at
www.sec.gov. APDN undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170512005451/en/
Investors:Applied DNA Sciences, Inc.Debbie Bailey,
631-240-8817debbie.bailey@adnas.comorLHASanjay M. Hurry,
212-838-3777shurry@lhai.comorWeb:
www.adnas.comTwitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024